Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-009591
Filing Date
2022-04-19
Accepted
2022-04-19 20:27:47
Documents
1
Period of Report
2022-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165041444722067.html 4  
1 FORM 4 wf-form4_165041444722067.xml 4 3856
  Complete submission text file 0001628280-22-009591.txt   5318
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 3329 CAY DRIVE SHERMAN OAKS CA 91423
Business Address
Patrick Kristin (Reporting) CIK: 0001769529 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37752 | Film No.: 22836112